How this company measures up on the fundamentals that matter
CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPS and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPS, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Trading near fair value at $97 (estimated $100). Passes all ethical screens. Ranks better than 88% of screened stocks.
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Trading characteristics and market positioning
Balance sheet strength and cash generation — the foundation of long-term value
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-21 | ROBBINS LARRY | Director | 3,372,000 | $317,471,136 | |
| 2026-05-14 | NORWALK LESLIE V | Director | 1,447 | $140,576 | |
| 2026-05-14 | BALSER JEFFREY R M.D., PH.D. | Director | 2,058 | $199,935 | |
| 2026-05-14 | SANSONE GUY P | Director | 1,447 | $140,576 | |
| 2026-05-14 | AGUIRRE FERNANDO | Director | 1,563 | $151,845 | |
| 2026-05-14 | BROWN C DAVID II | Director | 1,544 | $150,000 | |
| 2026-05-14 | KIRBY JOHN SCOTT | Director | 1,447 | $140,576 | |
| 2026-05-08 | MANDADI TILAK | Officer | 69,551 | $6,230,379 | |
| 2026-03-31 | KHICHI SAMRAT S | General Counsel | 12,531 | $899,976 | |
| 2026-03-31 | CAPOZZI HEIDI B | Officer | 10,025 | $719,996 |
Congressional trading disclosures involving this instrument
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-04-13 | Ro Khanna | Democrat | Purchase | 1K–15K |
| 2025-11-21 | Dwight Evans | Democrat | Sale | 1K–15K |
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15